Safety of Nabilone in reducing marijuana craving
Randomized double blind trial into the safety and efficacy of Cesemat for the treatment of marijuana use
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
35
1 mg capsule per day for 21 days
Vancouver General Hospital - Psychiatry Outpatient
Vancouver, British Columbia, Canada
Safety and tolerability to Nabilone
Marijuana craving questionnaire
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.